OBJECTIVE: Studies of infrainguinal lower extremity bypass for critical limb ischemia (CLI) have traditionally emphasized outcomes of patency, limb salvage, and death. Because functional outcomes are equally important, our objectives were to describe the proportion of CLI patients who did not achieve symptomatic improvement 1 year after bypass, despite having patent grafts, and identify preoperative factors associated with this outcome. METHODS: The prospectively collected Vascular Study Group of Northern New England database was used to identify all patients with elective infrainguinal lower extremity bypass for CLI (2003 to 2007) for whom long-term follow-up data were available. The primary composite study end point was clinical failure at 1 year after bypass, defined as amputation or persistent or worsened ischemic symptoms (rest pain or tissue loss), despite a patent graft. Variables identified on univariate screening (inclusion threshold, P < .20) were included in a multivariable logistic regression model to identify independent predictors. RESULTS: Long-term follow-up data were available for 1012 patients who underwent infrainguinal bypasses for CLI, of which 788 (78%) remained patent at 1 year. Of these, 79 (10%) met criteria for the composite end point of clinical failure: 21 (2.7%) for major amputations and 58 (7.4%) for persistent rest pain or tissue loss. In multivariable analysis, significant predictors of clinical failure included dialysis dependence (odds ratio [OR], 3.74; 95% confidence interval [CI], 1.84-7.62; P < .001) and preoperative inability to ambulate independently (OR, 2.17; 95% CI, 1.26-3.73; P = .005). A history of coronary artery bypass graft or percutaneous coronary intervention was protective (OR, 0.52; 95% CI, 0.29-0.93; P = .03). CONCLUSIONS: After infrainguinal lower extremity bypass for CLI, 10% of patients with a patent graft did not achieve clinical improvement at 1 year. Preoperative identification of this specific patient subgroup remains challenging. To improve surgical decision making and the overall care of CLI patients, further emphasis needs to be placed on functional outcomes in addition to traditional surgical end points. Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
OBJECTIVE: Studies of infrainguinal lower extremity bypass for critical limb ischemia (CLI) have traditionally emphasized outcomes of patency, limb salvage, and death. Because functional outcomes are equally important, our objectives were to describe the proportion of CLI patients who did not achieve symptomatic improvement 1 year after bypass, despite having patent grafts, and identify preoperative factors associated with this outcome. METHODS: The prospectively collected Vascular Study Group of Northern New England database was used to identify all patients with elective infrainguinal lower extremity bypass for CLI (2003 to 2007) for whom long-term follow-up data were available. The primary composite study end point was clinical failure at 1 year after bypass, defined as amputation or persistent or worsened ischemic symptoms (rest pain or tissue loss), despite a patent graft. Variables identified on univariate screening (inclusion threshold, P < .20) were included in a multivariable logistic regression model to identify independent predictors. RESULTS: Long-term follow-up data were available for 1012 patients who underwent infrainguinal bypasses for CLI, of which 788 (78%) remained patent at 1 year. Of these, 79 (10%) met criteria for the composite end point of clinical failure: 21 (2.7%) for major amputations and 58 (7.4%) for persistent rest pain or tissue loss. In multivariable analysis, significant predictors of clinical failure included dialysis dependence (odds ratio [OR], 3.74; 95% confidence interval [CI], 1.84-7.62; P < .001) and preoperative inability to ambulate independently (OR, 2.17; 95% CI, 1.26-3.73; P = .005). A history of coronary artery bypass graft or percutaneous coronary intervention was protective (OR, 0.52; 95% CI, 0.29-0.93; P = .03). CONCLUSIONS: After infrainguinal lower extremity bypass for CLI, 10% of patients with a patent graft did not achieve clinical improvement at 1 year. Preoperative identification of this specific patient subgroup remains challenging. To improve surgical decision making and the overall care of CLI patients, further emphasis needs to be placed on functional outcomes in addition to traditional surgical end points. Copyright (c) 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
Authors: Louis L Nguyen; Gregory L Moneta; Michael S Conte; Dennis F Bandyk; Alexander W Clowes; B Lynn Seely Journal: J Vasc Surg Date: 2006-11 Impact factor: 4.268
Authors: Hasan H Dosluoglu; Maureen S O'Brien-Irr; Jim Lukan; Linda M Harris; Maciej L Dryjski; Gregory S Cherr Journal: Am J Surg Date: 2006-11 Impact factor: 2.565
Authors: Tony S Das; Thomas McNamara; Bruce Gray; Gino J Sedillo; Brian R Turley; Kenneth Kollmeyer; Michael Rogoff; John E Aruny Journal: J Endovasc Ther Date: 2009-04 Impact factor: 3.487
Authors: Andres Schanzer; Philip P Goodney; Youfu Li; Mohammad Eslami; Jack Cronenwett; Louis Messina; Michael S Conte Journal: J Vasc Surg Date: 2009-07-22 Impact factor: 4.268
Authors: Andres Schanzer; Jessica Mega; Judith Meadows; Russell H Samson; Dennis F Bandyk; Michael S Conte Journal: J Vasc Surg Date: 2008-12 Impact factor: 4.268
Authors: Peter J Rossi; Christopher L Skelly; Shari L Meyerson; Hisham S Bassiouny; Daniel Katz; Lewis B Schwartz; James F McKinsey; Bruce L Gewertz; Tina R Desai Journal: Ann Vasc Surg Date: 2003-09-10 Impact factor: 1.466
Authors: Philip P Goodney; Lori L Travis; Brahmajee K Nallamothu; Kerianne Holman; Bjoern Suckow; Peter K Henke; F Lee Lucas; David C Goodman; John D Birkmeyer; Elliott S Fisher Journal: Circ Cardiovasc Qual Outcomes Date: 2011-12-06
Authors: Lawrence Oresanya; Shoujun Zhao; Siqi Gan; Brant E Fries; Philip P Goodney; Kenneth E Covinsky; Michael S Conte; Emily Finlayson Journal: JAMA Intern Med Date: 2015-06 Impact factor: 21.873
Authors: Catherine K Chang; Salvatore T Scali; Robert J Feezor; Adam W Beck; Alyson L Waterman; Thomas S Huber; Scott A Berceli Journal: J Vasc Surg Date: 2014-07-16 Impact factor: 4.268
Authors: Gregory J Landry; Nick O Esmonde; Jason R Lewis; Amir F Azarbal; Timothy K Liem; Erica L Mitchell; Gregory L Moneta Journal: J Vasc Surg Date: 2014-03-07 Impact factor: 4.268
Authors: Tze-Woei Tan; Alik Farber; Naomi M Hamburg; Robert T Eberhardt; Denis Rybin; Gheorghe Doros; Jens Eldrup-Jorgensen; Philip P Goodney; Jack L Cronenwett; Jeffrey A Kalish Journal: J Am Coll Surg Date: 2013-03-25 Impact factor: 6.113
Authors: Philip P Goodney; Kerianne Holman; Peter K Henke; Lori L Travis; Justin B Dimick; Therese A Stukel; Elliott S Fisher; John D Birkmeyer Journal: J Vasc Surg Date: 2013-02-01 Impact factor: 4.268